Michael Wong is an emeritus board member of the Harvard Business School Healthcare Alumni Association (HBSHAA).
In this installment of the Harvard Business School Healthcare Alumni Association (HBSHAA) Q&A series, Percival Barretto-Ko, President of Astellas Pharma, US, speaks to Michael Wong about why value and innovation are the top two focus areas to add to resumes in 2020.
Dr. George Westerman talks to Michael Wong about how smarter executives will successfully lead their workforces in a post COVID-19 business environment.
Dr. Geeta Vemuri, founder of biopharma investment firm Agent Capital, talks about sustaining a career in the venture capital sector.
Michael Wong speaks to Wayne Yetter (founding CEO of AstraMerck) and Renold (Ren) Capocasale, CEO of FlowMetric Life Sciences, about making the transition from a Fortune 500 firm to a startup.
Dr. Johnny Khouri of CVS Health talks about how, even amid COVID-19, innovation can lead to role changes for individuals and continuous learning opportunities that employees can leverage.
Mariano García-Valiño and Renato De Giorgi, co-founders of Axenya, discuss the importance of timing in becoming a successful entrepreneur.
Harvard Business School's Dr. Lynda Applegate talks about how business leaders in the healthcare space are identifying opportunities not just to accelerate through the COVID-19 crisis, but to thrive in the future.
The Harvard Business School’s Dr. Laura Huang on how executives can manage their career concerns during and after the COVID-19 crisis.
Dr. Jeanne Ross of the MIT Center for Information Systems Research discusses how to lead an organization’s digital transformation for the pursuit of new revenue models.
Rob Biederman, co-CEO of Catalant Technologies, on why biopharma employees should consider a new career path.
Korn Ferry's Dr. Paul Pospisil talks to HBSHAA's Michael Wong about why biopharma employees should be excited about the industry's prospects.
Michael Wong speaks to Dr. Marc Grodman about leading BioReference, his new role as CEO of Genosity, and the future of digital transformation.
Tina Tianning Yu, Chief Executive Officer of Mevion Medical Systems, talks about engaging with China's pharma market and laying the foundations for success in 2020 and beyond.
A discussion with Pam Cheng, executive vice president of Operations, Technology at AstraZeneca about making the transition into a Fortune 500 C-Suite role and leadership advice for success.
The next Q&A in the HBSHAA series, Career Insights for 2020, Michael Wong interviews Caitlin Hadtke Gagnon from J&J.
